Similarly, Noren et al. described in vivo EPHB4-mediated, Abl-Crk-dependent BC cell growth and motility, as well as invasion inhibition upon ephrin-B2-Fc treatment [47]. The gene discussed is EFNB2; the disease is breast cancer.